SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12699757
Source:
http://linkedlifedata.com/resource/pubmed/id/12699757
Search
Subject
(
66
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005508
,
umls-concept:C0020923
,
umls-concept:C0184511
,
umls-concept:C0332256
,
umls-concept:C0442027
,
umls-concept:C1517132
,
umls-concept:C1880355
pubmed:issue
9
pubmed:dateCreated
2003-4-17
pubmed:abstractText
A pyridyl moiety was introduced into a previously developed series of farnesyltransferase inhibitors containing imidazole and cyanophenyl (such as 4), resulting in potent inhibitors with improved pharmacokinetics.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9107377
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alkyl and Aryl Transferases
,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Farnesyltranstransferase
,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0960-894X
pubmed:author
pubmed-author:BauchJoyJ
,
pubmed-author:CohenJerryJ
,
pubmed-author:GuWen-ZhenWZ
,
pubmed-author:HasvoldLisaL
,
pubmed-author:LeonardNicholasN
,
pubmed-author:LiQunQ
,
pubmed-author:LiTongmeiT
,
pubmed-author:LinNan-HorngNH
,
pubmed-author:MarshKennanK
,
pubmed-author:RosenbergSaul HSH
,
pubmed-author:ShamHing LHL
,
pubmed-author:StollVincentV
,
pubmed-author:TongYunsongY
,
pubmed-author:WangLeL
,
pubmed-author:WangWeiboW
,
pubmed-author:ZhangHaiyingH
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1571-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12699757-Administration, Oral
,
pubmed-meshheading:12699757-Alkyl and Aryl Transferases
,
pubmed-meshheading:12699757-Animals
,
pubmed-meshheading:12699757-Biological Availability
,
pubmed-meshheading:12699757-Crystallography, X-Ray
,
pubmed-meshheading:12699757-Dogs
,
pubmed-meshheading:12699757-Drug Design
,
pubmed-meshheading:12699757-Enzyme Inhibitors
,
pubmed-meshheading:12699757-Farnesyltranstransferase
,
pubmed-meshheading:12699757-Haplorhini
,
pubmed-meshheading:12699757-Imidazoles
,
pubmed-meshheading:12699757-Models, Molecular
,
pubmed-meshheading:12699757-Nitriles
,
pubmed-meshheading:12699757-Stereoisomerism
,
pubmed-meshheading:12699757-Structure-Activity Relationship
pubmed:year
2003
pubmed:articleTitle
Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability.
pubmed:affiliation
R47B, AP10, Global Pharmaceutical R&D, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6101, USA. yunsong.tong@abbott.com
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, U.S. Gov't, Non-P.H.S.